PMDA drug package insert

アムロジピン錠2.5mg「VTRS」

PMDA Prescription drug · ヴィアトリス・ヘルスケア合同会社 · package insert May 20, 2026

Key facts

Brand names アムロジピン錠2.5mg「VTRS」, アムロジピン錠5mg「VTRS」, アムロジピン錠10mg「VTRS」, アムロジピンOD錠2.5mg「VTRS」, アムロジピンOD錠5mg「VTRS」, アムロジピンOD錠10mg「VTRS」
Nonproprietary names アムロジピンベシル酸塩
Companies 製造販売元/ヴィアトリス・ヘルスケア合同会社, 販売元/ヴィアトリス製薬合同会社
Product type Prescription drug
Therapeutic category 高血圧症・狭心症治療薬; 持続性Ca拮抗薬
Therapeutic category codes 872171
YJ codes 2171022F1487, 2171022F2483, 2171022F5393, 2171022F3366, 2171022F4362, 2171022F6306
Approval numbers 30200AMX00886, 30200AMX00887, 30200AMX00888, 30200AMX00889, 30200AMX00890, 30200AMX00891
Package insert edition 第8版
Package insert date May 20, 2026
PMDA document key 730869_2171022F1487_1
PMDA company code 730869

At a glance

  • 1–9 Package insert revisions
  • 10–99 Related PMDA documents
  • None Safety communications
  • No PMDA review report published
  • No Risk management plan (RMP)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMDA approved drugs and package inserts (Japan)

Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.

Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date:

Browse all PMDA approved drugs and package inserts (Japan)